AU7510394A - Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes - Google Patents

Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes

Info

Publication number
AU7510394A
AU7510394A AU75103/94A AU7510394A AU7510394A AU 7510394 A AU7510394 A AU 7510394A AU 75103/94 A AU75103/94 A AU 75103/94A AU 7510394 A AU7510394 A AU 7510394A AU 7510394 A AU7510394 A AU 7510394A
Authority
AU
Australia
Prior art keywords
16alpha
pregnanes
isopropylidenedioxy
17alpha
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75103/94A
Inventor
Georges Chriki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7510394A publication Critical patent/AU7510394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU75103/94A 1994-07-15 1994-07-15 Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes Abandoned AU7510394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1994/000693 WO1996002254A1 (en) 1994-07-15 1994-07-15 SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16'alpha',17'alpha'-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES

Publications (1)

Publication Number Publication Date
AU7510394A true AU7510394A (en) 1996-02-16

Family

ID=20393121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75103/94A Abandoned AU7510394A (en) 1994-07-15 1994-07-15 Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes

Country Status (2)

Country Link
AU (1) AU7510394A (en)
WO (1) WO1996002254A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019194B2 (en) 2001-02-09 2006-03-28 Lennart Hansson SCCE modified transgenic mammals and their use as models of human disease
AU2002251429B2 (en) * 2001-02-09 2007-01-18 Torbjorn Egelrud SCCE modified transgenic mammals and their use as models of human disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application

Also Published As

Publication number Publication date
WO1996002254A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU2616695A (en) Synergistic composition
AU6216296A (en) Pharmaceutical compositions
AU4762797A (en) Pharmaceutical compositions
AU3439895A (en) Disinfectant composition
AU5603094A (en) N,n-diacylpiperazine tachykinin antagonists
AU2967597A (en) Pharmaceutical compositions
AU5448998A (en) Synergistic algaecide
AU7309394A (en) Disinfectant composition
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU7961094A (en) Picosulphate dosage form
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
AU3716193A (en) Pharmaceutical compositions
AU3794595A (en) Pharmaceutical, orally applicable composition
AU3794795A (en) Pharmaceutical, orally applicable composition
AU3684293A (en) Disinfectant compositions
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU7508494A (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
AU3777897A (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
AU2531295A (en) Pharmaceutical composition
AU6377594A (en) Disinfectant compositions
AU3460897A (en) Medicinal compositions
AU8149294A (en) Disinfectant composition
AU7845098A (en) Pharmaceutical compositions comprising a 4-arylcoumarin for the treatment f vir al infections